Cargando…
Facilitating bias in cost-effectiveness analysis: CHEERS 2022 and the creation of assumption-driven imaginary value claims in health technology assessment
The current standards for health technology cost-effectiveness assessment rest on the creation of lifetime assumption-driven modeled simulations for imaginary pricing and consequent patient access recommendations. A recent BMJ paper reports a detailed assessment of 8,192 cost-effectiveness analyses,...
Autor principal: | Langley, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525991/ https://www.ncbi.nlm.nih.gov/pubmed/36226039 http://dx.doi.org/10.12688/f1000research.123709.1 |
Ejemplares similares
-
Nothing to Cheer About: Endorsing Imaginary Economic Evaluations and Value Claims with CHEERS 22
por: Langley, Paul
Publicado: (2022) -
Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021) -
Cheerfulness
Publicado: (1886) -
Cheerfulness
Publicado: (1886) -
Cheerfulness
Publicado: (1896)